Masayuki Nakajima Naoki Uchiyama Rie Shigemasa Takeshi Matsumura Ryota Matsuoka Akihiro Nomura
10.2169/internalmedicine.55.6738
Intern Med
2016;55(21):3151-3153.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/27803410/
Brain Neoplasms / diagnosis Carcinoid Tumor / diagnosis Lung Neoplasms / diagnosis Protein Kinase Inhibitors / therapeutic use Pyrazoles / therapeutic use Pyridines / therapeutic use Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
Brain Neoplasms / diagnosis Carcinoid Tumor / diagnosis Lung Neoplasms / diagnosis Protein Kinase Inhibitors / therapeutic use Pyrazoles / therapeutic use Pyridines / therapeutic use Receptor Protein-Tyrosine Kinases / antagonists & inhibitors Case Reports Aged Anaplastic Lymphoma Kinase Brain Neoplasms / drug therapy Brain Neoplasms / secondary Carcinoid Tumor / drug therapy Carcinoid Tumor / secondary Crizotinib Diagnosis, Differential Gene Rearrangement Humans In Situ Hybridization, Fluorescence Lung Neoplasms / drug therapy Lung Neoplasms / pathology Male Protein Kinase Inhibitors / administration & dosage Pyrazoles / administration & dosage Pyridines / administration & dosage Receptor Protein-Tyrosine Kinases / genetics Protein Kinase Inhibitors Pyrazoles Pyridines Crizotinib ALK protein, human Anaplastic Lymphoma Kinase Receptor Protein-Tyrosine Kinases
PMC5140865
27803410
Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
2016